Combined amphotericin B-flucytosine therapy in Aspergillus pneumonia.
1979
The incidence of aspergillosis is increasing while the prognosis remains dismal. Standard single-drug therapy with amphotericin B offers unacceptably low cure rates. A patient with Aspergillus pneumonia was treated with a synergistic combination of amphotericin B and flucytosine. A prompt clinical response and progressive resolution of the infection were observed. Combination therapy appeared to decrease the dose of amphotericin B needed for effective therapy. It may provide improved results with decreased toxic effects. ( JAMA 241:2418-2419, 1979)
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
7
References
36
Citations
NaN
KQI